Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03277989 · ClinicalTrials.gov registry record

INFINITY™Total Ankle Replacement Follow-up

A clinical trial, sponsored by Stryker Trauma and Extremities.

Terminated
Registry status
155
Enrollment target

NCT03277989 is a clinical trial that was terminated before completion, run by Stryker Trauma and Extremities. The registered enrollment target is 155 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03277989 was terminated before completion, sponsored by Stryker Trauma and Extremities.

TERMINATED
Registry status
155 participants
Enrollment target

Study Summary

Study Title INFINITY™Total Ankle Replacement Follow-up (ITAR) Study Design Prospective, multi-site, multi-year post-market clinical follow-up study Study Group Primary/Unilateral and/or bilateral Total Ankle Arthroplasty subjects implanted with INFINITY™ Total Ankle System Number of Subjects 150 with 9 sites

Trial Details

FieldValue
Enrollment Target 155 participants
Start Date 2017-10-09
Est. Completion 2023-03-31

Sponsor

Stryker Trauma and Extremities

30 total trials

What the Registry Record Tells You About NCT03277989

The ClinicalTrials.gov registry entry for NCT03277989 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 155 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stryker Trauma and Extremities, which has 30 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT03277989 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03277989 about?

NCT03277989 is a clinical study titled "INFINITY™Total Ankle Replacement Follow-up". Study Title INFINITY™Total Ankle Replacement Follow-up (ITAR) Study Design Prospective, multi-site, multi-year post-market clinical follow-up study Study Group Primary/Unilateral and/or bilateral Total Ankle Arthroplasty subjects implanted with INFINITY™ Total Ankle System Number of Subjects 150 wit...

What is the current status of trial NCT03277989?

This trial is currently terminated. The enrollment target is 155 participants. The study started on 2017-10-09. Estimated completion is 2023-03-31.

Who is sponsoring clinical trial NCT03277989?

This trial is sponsored by Stryker Trauma and Extremities, which has 30 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.